Company news

Faron Pharmaceuticals Oy news in 2021

Faron Pharmaceuticals Oy's news releases, calls and decks from 2021, newest first.

View company

Faron's financial calendar for 2022

December 21, 2021

Faron Announces Topline MATINS Biomarker Analysis

December 9, 2021

Change in Faron's Management Team

December 1, 2021

Faron to Present at Jefferies Conference 2021

November 16, 2021

Faron awarded EUR 3.8 Million in Arbitration Case

November 9, 2021

Cellular and Molecular Life Sciences Publication

November 3, 2021

Registration of Placing Shares with Trade Register

October 1, 2021

Presentation of Updated MATINS Data at ESMO

September 17, 2021

Faron Announces Presentation at ESMO Congress

September 9, 2021

Half-Year Financials, January 1 - June 30 2021

August 26, 2021

First Patient Dosed in Phase II/III COVID-19 Trial

August 25, 2021

Notice of Half-Year Report

July 28, 2021

Faron to Host KOL Webinar on Clever-1 Receptor

July 12, 2021

Updated corporate presentation

June 22, 2021

Bexmarilimab granted key US patent

June 14, 2021

Bexmarilimab results published in CCR

June 3, 2021

Bexmarilimab shows promising anti-tumour activity

May 17, 2021

US rights to patent related to Traumakine

May 14, 2021

Result of AGM

April 23, 2021

Appointment of a Broker

March 29, 2021

Exercise of Options

March 25, 2021

Bexmarilimab (Clevegen) development update

March 22, 2021

Faron to Present at Oppenheimer Conference

March 11, 2021

Notice of Full-Year Results and Annual Report

February 25, 2021

Registration of Placing Shares

February 12, 2021

Update on TRAUMAKINE development

January 26, 2021

US Department of Defense to support TRAUMAKINE

January 18, 2021

Faron to Present at H.C. Wainwright

January 4, 2021

Decks in 2021